Loudon Investment Management LLC grew its position in shares of Genpact Limited (NYSE:G - Free Report) by 9.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 141,425 shares of the business services provider's stock after buying an additional 12,490 shares during the quarter. Genpact accounts for 3.0% of Loudon Investment Management LLC's investment portfolio, making the stock its 7th largest holding. Loudon Investment Management LLC owned 0.08% of Genpact worth $5,545,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Capital International Investors boosted its position in shares of Genpact by 51.8% during the 1st quarter. Capital International Investors now owns 3,086,957 shares of the business services provider's stock worth $101,715,000 after purchasing an additional 1,053,236 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Genpact by 34.2% during the second quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider's stock worth $107,065,000 after buying an additional 847,249 shares in the last quarter. Pzena Investment Management LLC grew its position in Genpact by 130.3% during the second quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider's stock worth $37,465,000 after buying an additional 658,560 shares during the period. Los Angeles Capital Management LLC purchased a new position in Genpact in the third quarter valued at about $19,779,000. Finally, Tandem Investment Advisors Inc. purchased a new stake in Genpact during the 3rd quarter worth about $17,025,000. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Stock Up 1.6 %
G stock traded up $0.72 during midday trading on Monday, hitting $46.66. 1,418,006 shares of the company's stock were exchanged, compared to its average volume of 1,328,310. The stock has a market capitalization of $8.31 billion, a price-to-earnings ratio of 12.82, a price-to-earnings-growth ratio of 1.92 and a beta of 1.13. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.52. The firm has a 50 day moving average price of $39.18 and a 200-day moving average price of $35.68. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.05. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.15 billion. Genpact had a net margin of 14.22% and a return on equity of 22.09%. On average, analysts anticipate that Genpact Limited will post 2.85 EPS for the current year.
Genpact Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be issued a dividend of $0.1525 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.31%. Genpact's dividend payout ratio (DPR) is 16.76%.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the company. BMO Capital Markets raised their price objective on Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a report on Monday, August 12th. Robert W. Baird lifted their price target on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a report on Friday. Jefferies Financial Group increased their price objective on shares of Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a report on Monday, September 9th. TD Cowen raised their target price on shares of Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday. Finally, Needham & Company LLC upped their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday. Eight research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $42.33.
View Our Latest Research Report on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.